COYACoya Therapeutics Inc. Common Stock

4.870USD-2.01%Mkt Cap: 114.24M $P/E:

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on thera…

Key Statistics

Company
Market Cap114.24M $
Enterprise Value70.82M $
Revenue (TTM)8.02M $
Gross Profit-8.72M $
Net Income (TTM)-21.23M $
Revenue/Share0.4030 USD
Last Price4.870 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.82
PEG
EV/EBITDA-3.40
EV/Revenue8.83
P/S14.22
P/B2.63
EPS (TTM)-1.04
EPS (Forward)-1.73
52W Range
3.71029% of range7.750
52W High7.750 USD
52W Low3.710 USD
Profitability
Gross Margin-108.68%
Oper. Margin-2890.45%
EBITDA Margin-259.76%
Profit Margin-267.14%
ROE-49.33%
ROA-42.49%
Growth
Revenue Growth49.00%
Earnings Growth
Cash Flow & Leverage
Operating CF-10.74M $
CapEx (TTM)
FCF Margin-149.24%
FCF Yield-10.48%
Net Debt-43.18M $
Net Debt/EBITDA2.07
Balance Sheet
Debt/Equity
Current Ratio13.40
Quick Ratio12.29
Book Value/Sh1.845 USD
Cash/Share1.841 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.21 USD
Upside (mean)+212.4%
Target Range12.00 USD18.00 USD
$12.00+212.4% to mean$18.00
# Analysts7
Ownership
Shares Out.23.46M
Float17.29M
Insiders14.69%
Institutions33.23%
Short Interest
Short Ratio4.2d
Short % Float4.62%
Short % Out.4.57%
Shares Short1.07M
Short (prev mo.)914.91K
Technical
SMA 504.859 (+0.2%)
SMA 2004.925 (-1.1%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)192.63K
Avg Vol (10d)110.20K
Technical Indicators
RSI (14)55.0
MACD0.0282
MACD Signal-0.0389
MACD Hist.+0.0671
BB Upper5.121 USD
BB Middle4.504 USD
BB Lower3.886 USD
BB Width27.42%
ATR (14)0.2664 USD
Vol Ratio (20d)0.51x